IIN / IntriCon Corporation - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13

15-12B 1 brhc1003838615-12b.htm 15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-05005 Intricon Corporation (Exac

IIN / IntriCon Corporation / GAMCO INVESTORS, INC. ET AL Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 11) Intricon Corporation (Name of Issuer) Common stock, par value $1.00 per share (Title of Class of Securities) 46121H109 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number o

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2022 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-05005 23-1069060 (State or other jurisdiction of incorporation) (Commission File

AMENDED AND RESTATED ARTICLES OF INCORPORATION INTRICON CORPORATION

Exhibit 3.1 AMENDED AND RESTATED ARTICLES OF INCORPORATION OF INTRICON CORPORATION The Articles of Incorporation of Intricon Corporation, a Pennsylvania corporation (the ?Corporation?), are hereby amended and restated in their entirety as follows: FIRST: Name. The name of the Corporation is Intricon Corporation. SECOND: Registered Office. The name of the Corporation?s commercial registered office

As filed with the Securities and Exchange Commission on May 24, 2022

As filed with the Securities and Exchange Commission on May 24, 2022 Registration No.

As filed with the Securities and Exchange Commission on May 24, 2022

As filed with the Securities and Exchange Commission on May 24, 2022 Registration No.

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Termination of a Material Definitive Agreement, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2022 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission File

As filed with the Securities and Exchange Commission on May 24, 2022

As filed with the Securities and Exchange Commission on May 24, 2022 Registration No.

As filed with the Securities and Exchange Commission on May 24, 2022

As filed with the Securities and Exchange Commission on May 24, 2022 Registration No.

As filed with the Securities and Exchange Commission on May 24, 2022

As filed with the Securities and Exchange Commission on May 24, 2022 Registration No.

As filed with the Securities and Exchange Commission on May 24, 2022

As filed with the Securities and Exchange Commission on May 24, 2022 Registration No.

As filed with the Securities and Exchange Commission on May 24, 2022

As filed with the Securities and Exchange Commission on May 24, 2022 Registration No.

As filed with the Securities and Exchange Commission on May 24, 2022

As filed with the Securities and Exchange Commission on May 24, 2022 Registration No.

As filed with the Securities and Exchange Commission on May 24, 2022

As filed with the Securities and Exchange Commission on May 24, 2022 Registration No.

As filed with the Securities and Exchange Commission on May 24, 2022

As filed with the Securities and Exchange Commission on May 24, 2022 Registration No.

As filed with the Securities and Exchange Commission on May 24, 2022

As filed with the Securities and Exchange Commission on May 24, 2022 Registration No.

AMENDED & RESTATED BY-LAWS OF INTRICON CORPORATION (a Pennyslvania Business Corporation, the “Corporation”) Adopted as of May 24, 2022 ARTICLE 1 OFFICES; REGISTERED AGENT

Exhibit 3.2 AMENDED & RESTATED BY-LAWS OF INTRICON CORPORATION (a Pennyslvania Business Corporation, the ?Corporation?) Adopted as of May 24, 2022 ARTICLE 1 OFFICES; REGISTERED AGENT Section 1.1 Registered Office and Agent. The Corporation shall maintain in the Commonwealth of Pennsylvania a registered office and a registered agent whose business office is identical with such registered office. Se

As filed with the Securities and Exchange Commission on May 24, 2022

As filed with the Securities and Exchange Commission on May 24, 2022 Registration No.

Intricon Announces Completion of Acquisition by an Affiliate of

Exhibit 99.1 Intricon Announces Completion of Acquisition by an Affiliate of Altaris Capital Partners Investment by Altaris Supports Intricon?s Ability to Deliver Innovative Solutions and Service to its Customers ARDEN HILLS, Minn., May 24, 2022 - Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and pa

IIN / IntriCon Corporation / GAMCO INVESTORS, INC. ET AL Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 10) Intricon Corporation (Name of Issuer) Common stock, par value $1.00 per share (Title of Class of Securities) 46121H109 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number o

IIN / IntriCon Corporation / GAMCO INVESTORS, INC. ET AL Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 9) Intricon Corporation (Name of Issuer) Common stock, par value $1.00 per share (Title of Class of Securities) 46121H109 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 18, 2022 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission File N

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number:

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? ? ? Filed by a party other than the Registrant ? ? ?? Check the appropriate box: ?? Preliminary Proxy Statement ?? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)

Calculation of Filing Fee Tables SCHEDULE 14A (Form Type) INTRICON CORPORATION (Exact Name of Registrant as Specified in its Charter) Table 1: Transaction Valuation

Exhibit 107 EX-FILING FEES Calculation of Filing Fee Tables SCHEDULE 14A (Form Type) INTRICON CORPORATION (Exact Name of Registrant as Specified in its Charter) Table 1: Transaction Valuation Proposed Maximum Aggregate Value of Transaction Fee Rate Amount of Filing Fee Fees to be Paid $ 240,866,773.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? ? ? Filed by a party other than the Registrant ? ? ?? Check the appropriate box: ? Preliminary Proxy Statement ?? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(

IIN / IntriCon Corporation / GAMCO INVESTORS, INC. ET AL Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 8) Intricon Corporation (Name of Issuer) Common stock, par value $1.00 per share (Title of Class of Securities) 46121H109 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Mark one) ? ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 1-5005 INTRICON CORPO

IIN / IntriCon Corporation / Beryl Capital Management LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Intricon Corporation (Name of Issuer) Common Stock, par value $1.00 (Title of Class of Securities) 46121H109 (CUSIP Number) March 25, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to

As filed with the Securities and Exchange Commission on March 28, 2022

As filed with the Securities and Exchange Commission on March 28, 2022 Registration No.

Filing Fee Table

EXHIBIT 107.1 Calculation of Filing Fee Table Form S-8 (Form Type) IntriCon Corporation (Exact Name of Registrant as Specified in its Charter) Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(3) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common stock, par value $1.00 pe

IIN / IntriCon Corporation / GAMCO INVESTORS, INC. ET AL Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 7) Intricon Corporation (Name of Issuer) Common stock, par value $1.00 per share (Title of Class of Securities) 46121H109 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of

Form of Amendment No.1 to Employment Agreements with Michael Geraci and Dennis Gonsior dated as of June 14, 2021.*

Exhibit 10.9.5 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT This AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (?Amendment?) is made and dated as of June 14, 2021, between INTRICON CORPORATION, a Pennsylvania corporation (the ?Company?), and [NAME] (?Executive?). BACKGROUND Company and Executive are parties to an Employment Agreement dated as of October 7, 2007 (the ?Employment Agreement?). The parties desir

List of significant subsidiaries of the Company.

EXHIBIT 21.1 ? Significant Subsidiaries of Intricon Corporation ? Subsidiary Place of Incorporation ? Emerald Medical Services Pte., LTD Singapore ? Hearing Help Express, Inc. Illinois ? Intricon GmbH Vertrieb von Elecktronikteilen Germany ? Intricon, Inc. Minnesota ? Intricon PTE LTD. Singapore ? PT Intricon Indonesia Indonesia ? Emerald Extrusion Services LLC California ?

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark one) ? ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 1-500

Separation Agreement and General Release of Claims between the Company and Ellen Scipta dated as of November 14, 2021.

Exhibit 10.28 SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS THIS SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS (hereinafter referred to as the ?Agreement?) is being entered into between and among INTRICON CORPORATION (hereinafter referred to as the ?Company?) and ELLEN SCIPTA on behalf of and for the benefit of herself and her heirs, assigns and representatives (hereinafter referred to a

IIN / IntriCon Corporation / PALISADE CAPITAL MANAGEMENT LLC/NJ - SC 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4) * Intricon Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 46121H109 (CUSIP Number) March 1, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

IIN / IntriCon Corporation / GAMCO INVESTORS, INC. ET AL Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6) Intricon Corporation (Name of Issuer) Common stock, par value $1.00 per share (Title of Class of Securities) 46121H109 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of

Amendment to Amended and Restated Bylaws of Intricon Corporation.

Exhibit 3.1 Amendment to Bylaws Effective February 27, 2022 On February 27, 2022, the Board of Directors of Intricon Corporation (?Corporation?) adopted the following amendment to the Amended and Restated Bylaws of the Corporation: Amendment of Bylaws WHEREAS, the Board of Directors has determined that it is desirable and in the best interests of the Company and its shareholders that litigation in

Intricon Merger Agreement with Altaris Employee FAQs

Exhibit 99.1 Intricon Merger Agreement with Altaris Employee FAQs Who is acquiring us and why does it make sense for our shareholders and our business? Affiliates of Altaris Capital Partners, LLC (which collectively with its affiliates is referred to in this document as ?Altaris?) have signed a merger agreement to acquire Intricon. Altaris is an investment firm focused exclusively on the healthcar

Agreement and Plan of Merger, dated as of February 27, 2022, by and among Intricon Corporation, IIN Holding Company LLC and IC Meger Sub Ince. (Incorporated by reference from the Company's Current Report on Form 8-K filed with the Commission on March 1, 2022.)

Exhibit 2.1 [EXECUTION COPY] AGREEMENT AND PLAN OF MERGER by and among INTRICON CORPORATION, IIN HOLDING COMPANY LLC and IC MERGER SUB INC. Dated as of February 27, 2022 Table of Contents Page Article I The Merger 2 1.1 The Merger 2 1.2 Effective Time of the Merger 2 1.3 Closing 2 1.4 Effects of the Merger 2 1.5 Directors and Officers of the Surviving Corporation 2 1.6 Conversion of Capital Stock

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 27, 2022 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 27, 2022

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 27, 2022 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission F

Intricon Enters into Agreement to be Acquired by an Affiliate of Altaris Capital Partners for $241 Million Intricon Shareholders to Receive $24.25 Per Share in Cash

Intricon Enters into Agreement to be Acquired by an Affiliate of Altaris Capital Partners for $241 Million Intricon Shareholders to Receive $24.

Intricon Reports Fourth Quarter and Full Year 2021 Results

Intricon Reports Fourth Quarter and Full Year 2021 Results ARDEN HILLS, Minn. ? February 28, 2022 ? Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for its fourth quarter and year ended

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 28, 2022 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 28, 2022

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 28, 2022 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission F

IIN / IntriCon Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: IntriCon Corp. Title of Class of Securities: Common Stock CUSIP Number: 46121H109 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule

IIN / IntriCon Corporation / PALISADE CAPITAL MANAGEMENT LLC/NJ - SC 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3) * Intricon Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 46121H109 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is fil

IIN / IntriCon Corporation / GAMCO INVESTORS, INC. ET AL Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5) Intricon Corporation (Name of Issuer) Common stock, par value $1.00 per share (Title of Class of Securities) 46121H109 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 29, 2021 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Num

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 8, 2021 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission Fi

INTRICON REPORTS THIRD QUARTER 2021 RESULTS

INTRICON REPORTS THIRD QUARTER 2021 RESULTS ARDEN HILLS, Minn. ? November 8, 2021 ? Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for its third quarter ended September 30, 2021. Third

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 29, 2021 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission Fi

Intricon Announces CFO Departure and Preliminary Third Quarter 2021 Revenue

Exhibit 99.1 Intricon Announces CFO Departure and Preliminary Third Quarter 2021 Revenue ARDEN HILLS, Minn. October 29, 2021 - Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, announced today that Ellen Scipta has steppe

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 11, 2021 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission Fil

INTRICON CORPORATION Reconciliation of Adjusted Net (Loss) Income and Earnings Per Share Fiscal Year 2020

INTRICON CORPORATION Reconciliation of Adjusted Net (Loss) Income and Earnings Per Share Fiscal Year 2020 (Unaudited) Use of non-GAAP Adjusted Financial Measures This statement contains financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 9, 2021 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-5005 INTRICON CO

INTRICON REPORTS SECOND QUARTER 2021 RESULTS

INTRICON REPORTS SECOND QUARTER 2021 RESULTS ARDEN HILLS, Minn. ? August 9, 2021 ? Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for its second quarter ended June 30, 2021. Second Qua

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 26, 2021 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission File

Exhibit 1.01 – Conflict Minerals Report of IntriCon Corporation for calendar year 2020

Exhibit 1.01 Conflict Minerals Report of IntriCon Corporation in Accordance with Rule 13p-1 under the Securities Exchange Act of 1934 Explanatory Note This is the Conflict Minerals Report (the "Report") of IntriCon Corporation (the "Company") for calendar year 2020 in accordance with Rule 13p-1 ("Rule 13p-1") under the Securities Exchange Act of 1934 (the "1934 Act"). Please refer to Rule 13p-1, F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report IntriCon Corporation (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report IntriCon Corporation (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) 1260 Red Fox Road, Arden Hills, Minnesota 55112 (Address of p

INTRICON REPORTS FIRST QUARTER 2021 RESULTS

INTRICON REPORTS FIRST QUARTER 2021 RESULTS ARDEN HILLS, Minn. ? May 10, 2021 ? Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for its first quarter ended March 31, 2021. First Quarter Highlights: ? Revenue

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-5005 INTRICON C

Form of Restricted Stock Unit Agreement issued to directors pursuant to the Amended and Restated 2015 Equity Incentive Plan.

Exhibit 10.4 ? ?Date? ?FullName? IntriCon Corporation 1260 Red Fox Road Arden Hills, MN 55112 Dear ?M1stName?: I am pleased to inform you that on ?GrantDate?, you were awarded an automatic grant of Restricted Stock Units for shares of Common Stock of the Company (?RSUs?) under the Company?s Amended and Restated 2015 Equity Incentive Plan (the ?Plan?), subject to the restrictions and on the terms a

Form of Performance Restricted Stock Unit Agreement issued to employees pursuant to the Amended and Restated 2015 Equity Incentive Plan.

Exhibit 10.5 ? ?GrantDate? ?FullName? IntriCon Corporation 1260 Red Fox Road Arden Hills, MN 55112 Dear ?M1stName?: I am pleased to inform you that on ?GrantDate? the Compensation Committee (the ?Committee?) of the Board of Directors of Intricon Corporation granted you Performance Restricted Stock Units for shares of Common Stock of the Company (?PRSUs?) under the Company?s Amended and Restated 20

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 10, 2021 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission File N

Form of Restricted Stock Unit Agreement issued to employees pursuant to the Amended and Restated 2015 Equity Incentive Plan.

Exhibit 10.3 ?Date? ?FullName? IntriCon Corporation 1260 Red Fox Road Arden Hills, MN 55112 Dear ?M1stName?: I am pleased to inform you that on ?GrantDate? the Compensation Committee (the ?Committee?) of the Board of Directors of Intricon Corporation granted you Restricted Stock Units for shares of Common Stock of the Company (?RSUs?) under the Company?s Amended and Restated 2015 Equity Incentive

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 4, 2021 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission File Nu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.__)* Intricon Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 46121H 10 9 (CUSIP Num

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.)* Intricon Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 46121H 10 9 (CUSIP Number) Francis E. Dehel Blank Rome LLP One Logan Square Philadelphia, PA 19103 (215) 569-5500 (Name, Address and Telephone Number of Person Authorized to

Intricon Appoints Kathleen Pepski to its Board of Directors

Exhibit 99.1 Intricon Appoints Kathleen Pepski to its Board of Directors ARDEN HILLS, Minn. – March 22, 2021 – Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering, and manufacturing miniature interventional, implantable and body-worn medical devices, today announced the appointment of Kathleen Pepski to the company’s Board of Directors, effect

Amended and Restated 2015 Equity Incentive Plan (incorporated by reference from Appendix A to the Company’s Proxy Statement filed with the Securities and Exchange Commission on March 22, 2021).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)

Amended and Restated Bylaws dated as of March 19, 2021.

Exhibit 3.1 AMENDED AND RESTATED BY-LAWS of INTRICON CORPORATION (A Pennsylvania Corporation) I. MEETINGS OF SHAREHOLDERS Section 1.01. Place of Meeting. Meetings of shareholders of the Corporation shall be held at such place, within the Commonwealth of Pennsylvania or elsewhere, as may be fixed by the Board of Directors; provided, however, that the Board of Directors may determine, in their sole

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 19, 2021 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission File

Annual Report - 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark one) T ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ? TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 1-5005 INTRICON CORPORA

Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934.

Exhibit 4.2 DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 ? Intricon Corporation has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the ?Exchange Act?): our common stock, par value $1.00 per share (the ?common stock?). References herein to ?we,? ?us? and ?our company? refe

List of significant subsidiaries of the Company

EXHIBIT 21.1 ? Significant Subsidiaries of Intricon Corporation ? ? Subsidiary Place of Incorporation ? Emerald Medical Services Pte., LTD Singapore ? Hearing Help Express, Inc. Illinois ? Intricon GmbH Vertrieb von Elecktronikteilen Germany ? Intricon, Inc. Minnesota ? Intricon PTE LTD. Singapore ? PT Intricon Indonesia Indonesia ? Emerald Extrusion Services LLC California ?

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 25, 2021 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission F

INTRICON REPORTS FOURTH QUARTER AND FULL YEAR 2020 RESULTS

Exhibit 99.1 INTRICON REPORTS FOURTH QUARTER AND FULL YEAR 2020 RESULTS ARDEN HILLS, Minn. ? February 25, 2021 ? Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering, and manufacturing miniature interventional, implantable and body-worn medical devices, today announced financial results for its fourth quarter and year ended December 31, 2020. F

SCHEDULE 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* IntriCon Corp (Name of Issuer) Common Stock (Title of Class of Securities) 46121H109 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2) * Intricon Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 46121H109 (CUSIP Number) December 3

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2) * Intricon Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 46121H109 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is fil

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: IntriCon Corp. Title of Class of Securities: Common Stock CUSIP Number: 46121H109 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(b) ☐ Rule 13d

Intricon Corporation Announces Appointment of Chief Financial Officer

Intricon Corporation Announces Appointment of Chief Financial Officer ARDEN HILLS, Mn.

Financial Statements and Exhibits, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 5, 2021 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission Fi

Employment Agreement between the Company and Ellen Scipta dated as of February 5, 2021. (Incorporated by reference from the Company’s Current Report on Form 8-K filed with the Commission on February 8, 2021.)

Exhibit 10.1 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (“Agreement”) is made and dated as of February 5, 2021, between INTRICON CORPORATION, a Pennsylvania corporation (the “Company”), and Ellen Scipta (“Executive”). Background Executive desires to be in the employ of the Company in the capacity of Chief Financial Officer, on the terms and conditions contained in this Agreement. Executive wil

(Name of Registrant as Specified in Charter)

OMB APPROVAL UNITED STATES OMB Number: 3235-0058 SECURITIES AND EXCHANGE COMMISSION Expires: February 28, 2022 WASHINGTON D.

INTRICON CORPORATION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-5005 INTRIC

INTRICON REPORTS THIRD QUARTER 2020 RESULTS

Exhibit 99.1 INTRICON REPORTS THIRD QUARTER 2020 RESULTS ARDEN HILLS, Minn. — November 9, 2020 — Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced financial results for its third quarter ended September 30, 2020. “Third quarter results incl

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8K DATED NOVEMBER 9, 2020

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 9, 2020 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission Fi

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - FORM 8K DATED OCTOBER 27, 2020

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 27, 2020 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission Fi

Amended and Restated 2015 Equity Incentive Plan. (Incorporated by reference to Appendix A to the Company’s Proxy Statement filed with the Securities and Exchange Commission on March 22, 2021.)

Exhibit 10.1 INTRICON CORPORATION AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN 1. Purposes The purposes of the Intricon Corporation Amended and Restated 2015 Equity Incentive Plan (the “Plan”) are to (i) promote the long-term retention of employees of Intricon Corporation (“Intricon”), and its current and future subsidiaries (collectively, the “Company”), directors of Intricon and other persons

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8K DATED OCTOBER 21, 2020

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 21, 2020 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission Fi

Employment Agreement between the Company and Scott Longval dated as of October 1, 2020. (Incorporated by reference from the Company’s Current Report on Form 8-K filed with the Commission on October 26, 2020.)

Exhibit 10.1 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (“Agreement”) is made and dated as of October 1, 2020, between INTRICON CORPORATION, a Pennsylvania corporation (the “Company”), and Scott Longval (“Executive”). Background Executive served as the Executive Vice President, Chief Operating Officer and Chief Financial Officer of the Company through September 30, 2020 and became the Presiden

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - 8-K DATED SEPTEMBER 8, 2020

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 8, 2020 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission F

IIN / Intricon Corp. / GAMCO INVESTORS, INC. ET AL Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4) Intricon Corporation (Name of Issuer) Common stock, par value $1.00 per share (Title of Class of Securities) 46121H109 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of

INTRICON REPORTS SECOND QUARTER 2020 RESULTS

Exhibit 99.1 INTRICON REPORTS SECOND QUARTER 2020 RESULTS ARDEN HILLS, Minn. — August 10, 2020 — IntriCon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced financial results for its second quarter ended June 30, 2020. “The IntriCon team continued to

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-5005 INTRICON CO

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 10, 2020 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission Fil

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 13, 2020 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 25, 2020 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission File

Transition Agreement by and between Mark S. Gorder and the Company dated as of June 29, 2020. (Incorporated by reference from the Company’s Current Report on Form 8-K filed with the Commission on June 30, 2020.)

June 29, 2020 Mr. Mark Gorder c/o IntriCon Corporation 1260 Red Fox Road Arden Hills, MN 55112 Re: Transition Agreement Dear Mark: This Transition Agreement (“Agreement”) is intended to set forth the terms of your (“Mark,” “you” or “your”) retirement from employment with IntriCon Corporation and its direct and indirect subsidiaries (collectively referred to as “IntriCon”). The terms of the Agreeme

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 25, 2020 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission File

IntriCon Announces Chief Executive Officer Transition J. Scott Longval to Succeed Mark Gorder as President and CEO, Effective October 1, 2020

IntriCon Announces Chief Executive Officer Transition J. Scott Longval to Succeed Mark Gorder as President and CEO, Effective October 1, 2020 ARDEN HILLS, Minn. — June 25, 2020 — IntriCon Corporation (NASDAQ: IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced that Scott Longval, who has served as the company’s Chief

Exhibit 1.01— Conflict Minerals Report of IntriCon Corporation for calendar year 2019

Exhibit 1.01 Conflict Minerals Report of IntriCon Corporation in Accordance with Rule 13p-1 under the Securities Exchange Act of 1934 Explanatory Note This is the Conflict Minerals Report (the “Report”) of IntriCon Corporation (the “Company”) for calendar year 2019 in accordance with Rule 13p-1 (“Rule 13p-1”) under the Securities Exchange Act of 1934 (the “1934 Act”). Please refer to Rule 13p-1, F

- FORM SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report IntriCon Corporation (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) 1260 Red Fox Road, Arden Hills, Minnesota 55112 (Address of p

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-5005 INTRICON C

CORPORATE PARTICIPANTS

Exhibit 99.1 MAY 19, 2020 / 9:00PM GMT, IIN - Q1 2020 IntriCon Corp Earnings Call CORPORATE PARTICIPANTS J. Scott Longval IntriCon Corporation - Executive VP, CFO, COO, Treasurer & Secretary Mark S. Gorder IntriCon Corporation - CEO, President & Director CONFERENCE CALL PARTICIPANTS Andrew Jacob D'Silva B. Riley FBR, Inc., Research Division - Senior Analyst Jonathan David Block Stifel, Nicolaus &

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 19, 2020 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission File N

IntriCon Acquires Emerald Medical Services

Exhibit 99.2 IntriCon Acquires Emerald Medical Services · Synergistic joint development and manufacturing capability expands market opportunity in surgical navigation · Provides immediate access to technology platform serving new high growth medical end-markets with complex interventional catheters · Accretive transaction delivers long-term revenue growth potential and diversifies customer base AR

Amended and Restated Revolving Note from the Company, Intricon, Inc. and Hearing Help Express, Inc. to CIBC Bank USA (formerly known as The PrivateBank and Trust Company), dated May 13, 2020. (Incorporated by reference from the Company’s Current Report on Form 8-K filed with the Commission on May 20, 2020.)

Exhibit 10.2 AMENDED AND RESTATED REVOLVING NOTE $12,000,000 Minneapolis, Minnesota May 13, 2020 FOR VALUE RECEIVED, the undersigned, INTRICON CORPORATION, a Pennsylvania corporation, INTRICON, INC., a Minnesota corporation, and HEARING HELP EXPRESS, INC., an Illinois corporation (each, a “Borrower”; collectively, the “Borrowers”), hereby JOINTLY AND SEVERALLY promise to pay to the order of CIBC B

Fourteenth Amendment to Loan and Security Agreement and Waiver among the Company, Intricon, Inc., Hearing Help Express, Inc., and CIBC Bank USA (formerly known as The PrivateBank and Trust Company), dated as of May 13, 2020. (Incorporated by reference from the Company’s Current Report on Form 8-K filed with the Commission on May 20, 2020.)

Exhibit 10.1 FOURTEENTH AMENDMENT TO Loan AND SECURITY AGREEMENT AND WAIVER THIS FOURTEENTH AMENDMENT TO Loan AND SECURITY AGREEMENT AND WAIVER (this “Amendment”) is made and entered into as of May 13, 2020, by and among INTRICON CORPORATION, a Pennsylvania corporation (“IntriCon”), INTRICON, INC., a Minnesota corporation (“Inc.”), HEARING HELP EXPRESS, INC., an Illinois corporation (“HHE”, and, t

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Material Impairments, Costs Associated with Exit or Disposal Activities, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Results of Operations and Financial Condition, Completion of Acquisition or Disposition of Assets, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 13, 2020 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission File N

INTRICON REPORTS FIRST QUARTER 2020 RESULTS

INTRICON REPORTS FIRST QUARTER 2020 RESULTS ARDEN HILLS, Minn. — May 19, 2020 — IntriCon Corporation (NASDAQ: IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced financial results for its first quarter ended March 31, 2020. Commenting on the recently completed quarter, Mark Gorder, president and chief executive office

Share Purchase Agreement dated as of May 18, 2020 among Intricon Pte. Ltd. , a wholly-owned subsidiary of Intricon Corporation, Emerald Medical Services Pte., Ltd., a Singapore company (“EMS”), and the direct and indirect owners of EMS. (Incorporated by reference from the Company’s Current Report on Form 8-K filed with the Commission on May 20, 2020.)

Exhibit 2.1 EXECUTION VERSION Share Purchase Agreement in relation to the acquisition of the entire issued share capital of Emerald Medical Services Pte. Ltd. Dated 18 May 2020 (1) Intricon Pte. Ltd. (2) Emerald Apex Pte. Ltd. (3) Michael Joseph O’Connor (4) River Source Medical Pte. Ltd. (5) Mark Albert Kempf (6) Steven Paul Wiesner (7) Emerald Medical Services Pte. Ltd. EXECUTION VERSION Content

Other Events

8-K 1 intricon2007928k.htm 8-K DATED MAY 8, 2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 8, 2020 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other j

-

May 8, 2020 VIA EDGAR U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attn: SiSi Cheng and Ernest Greene Re: IntriCon Corporation Form 10-K for the fiscal year ended December 31, 2019 Filed March 16, 2020 File No. 001-05005 Dear Ms. Cheng and Mr. Greene: The Company hereby submits its responses to comments raised in the Staff’s letter, dated April 29, 2019 (the “C

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 28, 2020 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission Fil

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 6, 2020 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission File

INTRICON OFFERS COVID-19 RELATED BUSINESS UPDATE Provides Preliminary First Quarter 2020 Results; Withdraws Full Year 2020 Guidance

INTRICON OFFERS COVID-19 RELATED BUSINESS UPDATE Provides Preliminary First Quarter 2020 Results; Withdraws Full Year 2020 Guidance ARDEN HILLS, Minn.

IIN / Intricon Corp. DEFA14A - - DEFINITIVE ADDITIONAL MATERIALS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin

IntriCon Corporation Announces Change to Virtual Meeting Format for its Annual Meeting of Shareholders to be Held on April 28, 2020

Exhibit 99.1 IntriCon Corporation Announces Change to Virtual Meeting Format for its Annual Meeting of Shareholders to be Held on April 28, 2020 ARDEN HILLS, Minn. — March 31, 2020 — IntriCon Corporation (NASDAQ: IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced a change in the location of its Annual Meeting of Shar

Regulation FD Disclosure, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 27, 2020 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission Fil

Amended and Restated Bylaws dated as of March 27, 2020.

Exhibit 3.1 AMENDED AND RESTATED BY-LAWS of INTRICON CORPORATION (A Pennsylvania Corporation) I. MEETINGS OF SHAREHOLDERS Section 1.01. Place of Meeting. Meetings of shareholders of the Corporation shall be held at such place, within the Commonwealth of Pennsylvania or elsewhere, as may be fixed by the Board of Directors; provided, however, that the Board of Directors may determine, in their sole

IIN / Intricon Corp. 10-K - Annual Report - FORM 10K DATED DECEMBER 31, 2019

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark one) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 1-5005 INTRICON CORPORA

IIN / Intricon Corp. DEF 14A - - DEFINITIVE PROXY STATEMENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)

IIN / Intricon Corp. DEFA14A - - DEFA 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant, Changes in Control of Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 21, 2020 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission

List of significant subsidiaries of the Company.

EXHIBIT 21.1 Significant Subsidiaries of IntriCon Corporation Subsidiary Place of Incorporation IntriCon GmbH Vertrieb von Elecktronikteilen Germany IntriCon, Inc. Minnesota IntriCon PTE LTD. Singapore PT IntriCon Indonesia Indonesia Hearing Help Express, Inc. Illinois

Baker Tilly Virchow Krause, LLP letter dated March 13, 2020. (Incorporated by reference from the Company’s Current Report on Form 8-K/A filed with the Commission on March 13, 2020.)

Exhibit 16.2 [letterhead of Baker Tilly Virchow Krause, LLP] March 16, 2020 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by IntriCon Corporation (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K, as part of the Form 8-K/A of IntriCon Corporat

Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

Exhibit 4.2 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 IntriCon Corporation has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): our common stock, par value $1.00 per share (the “common stock”). References herein to “we,” “us” and “our company” refer

IIN / Intricon Corp. / GAMCO INVESTORS, INC. ET AL Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3) Intricon Corporation (Name of Issuer) Common stock, par value $1.00 per share (Title of Class of Securities) 46121H109 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of

INTRICON REPORTS FOURTH QUARTER AND FULL YEAR 2019 RESULTS

INTRICON REPORTS FOURTH QUARTER AND FULL YEAR 2019 RESULTS ARDEN HILLS, Minn. — February 24, 2020 — IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its fourth quarter and year ended December 31, 2019. Full Year 2019 Financial Highlights: ● Revenue of $113.5 million ○ Re

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 24, 2020 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission

IIN / Intricon Corp. / PALISADE CAPITAL MANAGEMENT LLC/NJ - SC 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) * Intricon Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 46121H109 (CUSIP Number) February 10, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is fil

IIN / Intricon Corp. / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* INTRICON CORP (Name of Issuer) Common Stock (Title of Class of Securities) 46121H109 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule i

IIN / Intricon Corp. / Wellington Trust Company, National Association Multiple Common Trust Funds Trust, Micro Cap Equity Portfolio - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* INTRICON CORPORATION (Name of Issuer) Common Stock (Title of Class of Securities) 46121H109 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this S

Baker Tilly Virchow Krause, LLP letter dated January 27, 2020. (Incorporated by reference from the Company’s Current Report on Form 8-K filed with the Commission on January 27, 2020.)

Exhibit 16.1 [letterhead of Baker Tilly Virchow Krause, LLP] January 27, 2020 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by IntriCon Corporation (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K, as part of the Form 8-K of IntriCon Corporat

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 21, 2020 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission F

Master Supply Agreement effective as of May 14, 2019 between Medtronic, Inc. and the Company and related Business Unit Supply Agreement and Automation Agreement (Certain provisions of this exhibit have been omitted pursuant to Item 601 (b)(10)(iv) of Regulation S-K.) (Incorporated by reference from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019.)

EXHIBIT 10.1 THE SYMBOL “[****]” DENOTES PLACES WHERE CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL, AND (ii) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED MASTER SUPPLY AGREEMENT This Master Supply Agreement is effective May 14, 2019 (the “Effective Date”) between: MEDTRONIC, INC. 710 Medtronic Parkway Minneapolis,

IIN / Intricon Corp. 10-Q - Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-5005 INTRIC

INTRICON REPORTS THIRD QUARTER 2019 RESULTS

INTRICON CORPORATION 8-K Exhibit 99.1 INTRICON REPORTS THIRD QUARTER 2019 RESULTS ARDEN HILLS, Minn. — November 4, 2019 — IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its third quarter ended September 30, 2019. Third Quarter Highlights: ● Revenue of $26.9 million ○ R

Regulation FD Disclosure, Results of Operations and Financial Condition, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 4, 2019 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission F

IIN / Intricon Corp. / GAMCO INVESTORS, INC. ET AL Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2) Intricon Corporation (Name of Issuer) Common stock, par value $1.00 per share (Title of Class of Securities) 46121H109 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of

IIN / Intricon Corp. / GAMCO INVESTORS, INC. ET AL Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) Intricon Corporation (Name of Issuer) Common stock, par value $1.00 per share (Title of Class of Securities) 46121H109 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of

IIN / Intricon Corp. / Gorder Mark Stephen - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5)* IntriCon Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 46121H 10 9 (CUSIP Number) Francis E. Dehel Blank Rome LLP One Logan Square Philadelphia, PA 19103 (215) 569-5500 (Name, Address and Telephone Number of Person Authorized t

IIN / Intricon Corp. / GAMCO INVESTORS, INC. ET AL Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Intricon Corporation (Name of Issuer) Common stock, par value $1.00 per share (Title of Class of Securities) 46121H109 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorized

IIN / Intricon Corp. 10-Q - Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-5005 INTRICON CO

INTRICON REPORTS SECOND QUARTER 2019 RESULTS

Exhibit 99.1 INTRICON REPORTS SECOND QUARTER 2019 RESULTS ARDEN HILLS, Minn. — August 6, 2019 — IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its second quarter ended June 30, 2019. Recent Highlights: ● Quarterly revenue of $29.3 million o Revenue from largest medical

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 6, 2019 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission Fil

IIN / Intricon Corp. / PALISADE CAPITAL MANAGEMENT LLC/NJ - SC 13G Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 IntriCon Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 46121H109 (CUSIP Number) July 19, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: x Rule 13d-1(b) ¨ Rule 13d-1(c) ¨ Rule 13d-1(d) CUSIP No.

INTRICON SIGNS NEW MULTI-YEAR AGREEMENT WITH ITS LARGEST CUSTOMER, FURTHER SUPPORTING LONG-TERM GROWTH OUTLOOK REPORTS PRELIMINARY UNAUDITED SECOND QUARTER 2019 REVENUE AND REVISES FULL YEAR 2019 GUIDANCE

Exhibit 99.1 INTRICON SIGNS NEW MULTI-YEAR AGREEMENT WITH ITS LARGEST CUSTOMER, FURTHER SUPPORTING LONG-TERM GROWTH OUTLOOK REPORTS PRELIMINARY UNAUDITED SECOND QUARTER 2019 REVENUE AND REVISES FULL YEAR 2019 GUIDANCE ARDEN HILLS, Minn. — July 18, 2019 — IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 12, 2019 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission File

Regulation FD Disclosure, Financial Statements and Exhibits, Material Impairments, Costs Associated with Exit or Disposal Activities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 25, 2019 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission Fi

IntriCon Repositions its Hearing Aid Sales in the UK through New Distribution Agreement, Sells Accessory Business Assets of UK Limited Subsidiary

Exhibit 99.1 IntriCon Repositions its Hearing Aid Sales in the UK through New Distribution Agreement, Sells Accessory Business Assets of UK Limited Subsidiary Shift Enables Significant Cost Reduction and Reallocation of Resources in Value-based Hearing Health ARDEN HILLS, Minn. — July 1, 2019 — IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and

Material Impairments, Costs Associated with Exit or Disposal Activities

8-K 1 intricon1914148k.htm 8-K DATED JUNE 25, 2019 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 25, 2019 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or ot

IIN / Intricon Corp. / Wellington Trust Company, National Association Multiple Common Trust Funds Trust, Micro Cap Equity Portfolio - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* INTRICON CORPORATION (Name of Issuer) Common Stock (Title of Class of Securities) 46121H109 (CUSIP Number) June 20, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedul

IIN / Intricon Corp. SD - - FORM SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report IntriCon Corporation (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) 1260 Red Fox Road, Arden Hills, Minnesota 55112 (Address of p

Exhibit 1.01— Conflict Minerals Report of IntriCon Corporation for calendar year 2018

Exhibit 1.01 Conflict Minerals Report of IntriCon Corporation in Accordance with Rule 13p-1 under the Securities Exchange Act of 1934 Explanatory Note This is the Conflict Minerals Report (the “Report”) of IntriCon Corporation (the “Company”) for calendar year 2018 in accordance with Rule 13p-1 (“Rule 13p-1”) under the Securities Exchange Act of 1934 (the “1934 Act”). Please refer to Rule 13p-1, F

IIN / Intricon Corp. 10-Q Quarterly Report 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-5005 INTRICON C

Amended and Restated Revolving Note from the Company, Intricon, Inc. and Hearing Help Express, Inc. to CIBC Bank USA (formerly known as The PrivateBank and Trust Company), dated April 17, 2019. (Incorporated by reference from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019.)

Exhibit 10.2 AMENDED AND RESTATED REVOLVING NOTE $7,000,000 Minneapolis, Minnesota April 17, 2019 FOR VALUE RECEIVED, the undersigned, INTRICON CORPORATION, a Pennsylvania corporation, INTRICON, INC., a Minnesota corporation, and HEARING HELP EXPRESS, INC., an Illinois corporation (each, a “Borrower"; collectively, the “Borrowers"), hereby JOINTLY AND SEVERALLY promise to pay to the order of CIBC

Thirteenth Amendment to Loan and Security Agreement among the Company, Intricon, Inc., Hearing Help Express, Inc. and CIBC Bank USA (formerly known as The PrivateBank and Trust Company), dated as of April 17, 2019. (Incorporated by reference from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019.)

Exhibit 10.1 THIRTEENTH AMENDMENT TO Loan AND SECURITY AGREEMENT THIS THIRTEENTH AMENDMENT TO Loan AND SECURITY AGREEMENT (this “Amendment") is made and entered into as of April 17, 2019, by and among INTRICON CORPORATION, a Pennsylvania corporation ("IntriCon"), INTRICON, INC., a Minnesota corporation ("Inc.”), HEARING HELP EXPRESS, INC., an Illinois corporation ("HHE", and, together with Inc., a

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 1, 2019 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission File N

IntriCon Announces Changes to Board of Directors and Leadership Team Promotions Raymond Huggenberger Appointed to Board of Directors Current Director Philip Smith Elected Chairman of the Board Chief Financial Officer Scott Longval Assumes Additional

Exhibit 99.2 IntriCon Announces Changes to Board of Directors and Leadership Team Promotions Raymond Huggenberger Appointed to Board of Directors Current Director Philip Smith Elected Chairman of the Board Chief Financial Officer Scott Longval Assumes Additional Role of Chief Operating Officer Michael Geraci, Dennis Gonsior and Greg Gruenhagen Promoted to Senior Vice President Roles ARDEN HILLS, M

INTRICON REPORTS FIRST QUARTER 2019 RESULTS

Exhibit 99.1 INTRICON REPORTS FIRST QUARTER 2019 RESULTS ARDEN HILLS, Minn. — April 29, 2019 — IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its first quarter ended March 31, 2019. Recent Highlights: ● Quarterly revenue of $30.1 million, an 18.7% increase over the pri

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 26, 2019 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission Fil

Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

8-K 1 intricon1908668k.htm FORM 8K DATED APRIL 17, 2019 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 17, 2019 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State

IIN / Intricon Corp. DEFINITIVE ADDITIONAL MATERIALS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)

IIN / Intricon Corp. DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)

List of significant subsidiaries of the Company.

EX-21.1 2 intricon190573ex21-1.htm LIST OF SIGNIFICANT SUBSIDIARIES OF THE COMPANY EXHIBIT 21.1 Significant Subsidiaries of IntriCon Corporation Subsidiary Place of Incorporation IntriCon GmbH Germany Vertrieb von Elecktronikteilen IntriCon UK Limited United Kingdom IntriCon, Inc. Minnesota IntriCon PTE LTD. Singapore PT IntriCon Indonesia Indonesia Hearing Help Express, Inc. Illinois

IIN / Intricon Corp. 10-K (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark one) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 1-5005 INTRICON CORPORA

INTRICON REPORTS FOURTH QUARTER AND FULL YEAR 2018 RESULTS Medical and Value Hearing Health Performance Drive Record Quarterly Revenue; Company Provides Guidance for 2019

INTRICON REPORTS FOURTH QUARTER AND FULL YEAR 2018 RESULTS Medical and Value Hearing Health Performance Drive Record Quarterly Revenue; Company Provides Guidance for 2019 ARDEN HILLS, Minn.

Regulation FD Disclosure, Results of Operations and Financial Condition, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 19, 2019 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission

IIN / Intricon Corp. FORM 10Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-5005 INTRIC

INTRICON REPORTS 2018 THIRD-QUARTER RESULTS Medical and Value Hearing Health Performance Drive Double-Digit Third Quarter Sales Gains and Profitability

INTRICON REPORTS 2018 THIRD-QUARTER RESULTS Medical and Value Hearing Health Performance Drive Double-Digit Third Quarter Sales Gains and Profitability ARDEN HILLS, Minn.

Regulation FD Disclosure, Results of Operations and Financial Condition, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 5, 2018 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission F

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 15, 2018 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission Fi

IntriCon Announces Pricing of 1,500,000 Shares of Common Stock

Exhibit 99.1 IntriCon Announces Pricing of 1,500,000 Shares of Common Stock ARDEN HILLS, Minn. — August 15, 2018 — IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of body-worn devices, today announced that it has priced an underwritten public offering of 1,500,000 shares of its common stock at a public offering price of $55.00 per share. The offering is expe

Underwriting Agreement, dated August 15, 2018, between IntriCon Corporation and Stifel, Nicolaus & Company, Incorporated, as representative of the several underwriters named therein.

Exhibit 1.1 Execution Version 1,500,000 Shares INTRICON CORPORATION Common Stock UNDERWRITING AGREEMENT August 15, 2018 Stifel, Nicolaus & Company, Incorporated As Representative of the Several Underwriters 787 Seventh Avenue New York, New York 10019 Dear Sirs: 1. Introductory. IntriCon Corporation, a Pennsylvania corporation (the “Company”), proposes to sell, pursuant to the terms of this Underwr

IntriCon Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

Exhibit 99.2 IntriCon Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares ARDEN HILLS, Minn. — August 20, 2018 — IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of body-worn devices, today announced the completion of its previously announced underwritten public offering of 1,725,0

1,500,000 Shares Common Stock

Filed pursuant to Rule 424(b)(5) Registration No. 333-226334 PROSPECTUS SUPPLEMENT (To Prospectus dated August 7, 2018) 1,500,000 Shares Common Stock We are offering 1,500,000 shares of our common stock pursuant to this prospectus supplement and the accompanying base prospectus. Our common stock trades on the Nasdaq Global Market under the symbol “IIN.” The last reported sale price of our common s

Equity Purchase Agreement, dated August 10, 2018, among IntriCon Corporation and certain directors and officers of IntriCon Corporation

Exhibit 10.1 INTRICON CORPORATION EQUITY PURCHASE AGREEMENT This EQUITY PURCHASE AGREEMENT (this “Agreement”) is dated as of August 10, 2018 by and among IntriCon Corporation, a Pennsylvania corporation (the “Company”), and the shareholders of the Company listed on Schedule I to this Agreement (each a “Holder” and collectively, the “Holders”). Background A. The Holders own, or have the right to ac

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 10, 2018 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission Fi

IntriCon Announces Proposed Public Offering of 1,500,000 Shares of Common Stock

Exhibit 99.1 IntriCon Announces Proposed Public Offering of 1,500,000 Shares of Common Stock ARDEN HILLS, Minn. — August 14, 2018 — IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of body-worn devices, today announced that it intends to offer and sell 1,500,000 shares of its common stock in an underwritten public offering. IntriCon also expects to grant to t

SUBJECT TO COMPLETION DATED AUGUST 14, 2018

Filed pursuant to Rule 424(b)(5) Registration No. 333-226334 The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying base prospectus are not an offer to sell these securities, and are not soliciting an offer to buy these securities, in any jurisdiction where the offer or sale is not permitted. SUBJECT

Amended and Restated Revolving Note from the Company, IntriCon, Inc. and Hearing Help Express, Inc. to CIBC Bank USA (formerly known as The PrivateBank and Trust Company), dated July, 23, 2018.

EXHIBIT 10.2 AMENDED AND RESTATED REVOLVING NOTE $11,000,000 Minneapolis, Minnesota July 23, 2018 FOR VALUE RECEIVED, the undersigned, INTRICON CORPORATION, a Pennsylvania corporation, INTRICON, INC., a Minnesota corporation, and HEARING HELP EXPRESS, INC., an Illinois corporation (each, a “Borrower”; collectively, the “Borrowers”), hereby JOINTLY AND SEVERALLY promise to pay to the order of CIBC

Twelfth Amendment to Loan and Security Agreement among the Company, Intricon, Inc., Hearing Help Express, Inc. and CIBC Bank USA (formerly known as The PrivateBank and Trust Company), dated as of July 23, 2018. (Incorporated by reference from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018.)

EXHIBIT 10.1 TWELFTH AMENDMENT TO Loan AND SECURITY AGREEMENT THIS TWELFTH AMENDMENT TO Loan AND SECURITY AGREEMENT (this “Amendment”) is made and entered into as of July 23, 2018, by and among INTRICON CORPORATION, a Pennsylvania corporation (“IntriCon”), INTRICON, INC., a Minnesota corporation (“Inc.”), HEARING HELP EXPRESS, INC., an Illinois corporation (“HHE”, and, together with Inc., and Intr

Amended and Restated CapEx Note from the Company, Intricon, Inc. and Hearing Help Express, Inc. to CIBC Bank USA (formerly known as The PrivateBank and Trust Company), dated July 23, 2018. (Incorporated by reference from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018).

EXHIBIT 10.3 AMENDED AND RESTATED CAPEX NOTE $10,000,000 Minneapolis, MN July 23, 2018 FOR VALUE RECEIVED, the undersigned, INTRICON CORPORATION, a Pennsylvania corporation, INTRICON, INC., a Minnesota corporation, and HEARING HELP EXPRESS, INC., an Illinois corporation (each, a “Borrower”; collectively, the “Borrowers”), hereby JOINTLY AND SEVERALLY promise to pay to the order of CIBC BANK USA (f

IIN / Intricon Corp. 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-5005 INTRICON CO

IIN / Intricon Corp. AMENDMENT TO FORM S-3

As filed with the Securities and Exchange Commission on August 6, 2018 Registration No.

IIN / Intricon Corp. CORRESP

IntriCon Corporation 1260 Red Fox Road Arden Hills, MN 55112 August 6, 2018 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.

[BLANK ROME LETTERHEAD] July 26, 2018

INTRICON CORPORATION S-8 POS Exhibit 5.4 [BLANK ROME LETTERHEAD] July 26, 2018 IntriCon Corporation 1260 Red Fox Road, Arden Hills, MN Arden Hills, MN 55112 Gentlemen: We have acted as counsel to you, IntriCon Corporation, a Pennsylvania corporation (the “Company”), in connection with the preparation of the Post-Effective Amendment (the “Post-Effective Amendment”) to the following Registration Sta

INTRICON CORPORATION S-8 POS

As filed with the Securities and Exchange Commission on July 26, 2018 Registration No.

IIN / Intricon Corp. S-3

As filed with the Securities and Exchange Commission on July 25, 2018 Registration No. 333-

INTRICON REPORTS 2018 SECOND-QUARTER RESULTS Medical and Value Hearing Health Performance Drive Double-Digit Second Quarter Sales Gains and Profitability

Exhibit 99.1 INTRICON REPORTS 2018 SECOND-QUARTER RESULTS Medical and Value Hearing Health Performance Drive Double-Digit Second Quarter Sales Gains and Profitability ARDEN HILLS, Minn. — July 25, 2018 — IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its second quarter

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 25, 2018 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission File

IIN / Intricon Corp. FORM SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report IntriCon Corporation (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction (Commission (IRS Employer of incorporation or organization) File Number) Identification No.) 1260 Red Fox Road, Arden Hills, Minnesota 55112 (Address of p

Conflict Minerals Report of IntriCon Corporation in Accordance with Rule 13p-1 under the Securities Exchange Act of 1934

Exhibit 1.01 Conflict Minerals Report of IntriCon Corporation in Accordance with Rule 13p-1 under the Securities Exchange Act of 1934 Explanatory Note This is the Conflict Minerals Report (the “Report”) of IntriCon Corporation (the “Company”) for calendar year 2017 in accordance with Rule 13p-1 (“Rule 13p-1”) under the Securities Exchange Act of 1934 (the “1934 Act”). Please refer to Rule 13p-1, F

IIN / Intricon Corp. CORRESP

IntriCon Corporation 1260 Red Fox Road Arden Hills, MN 55112 May 17, 2018 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.

IIN / Intricon Corp. 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-5005 INTRICON C

IIN / Intricon Corp. / HEARTLAND ADVISORS INC - SCHEDULE 13G Passive Investment

SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* IntriCon Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 46121H109 (CUSIP Number) April 30, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whi

IIN / Intricon Corp. S-3

As filed with the Securities and Exchange Commission on May 7, 2018 Registration No.

Regulation FD Disclosure, Results of Operations and Financial Condition, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 7, 2018 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission File N

INTRICON REPORTS 2018 FIRST-QUARTER RESULTS Medical and Value Hearing Health Performance Drive Double-Digit First Quarter Sales Gains and Profitability

Exhibit 99.1 INTRICON REPORTS 2018 FIRST-QUARTER RESULTS Medical and Value Hearing Health Performance Drive Double-Digit First Quarter Sales Gains and Profitability ARDEN HILLS, Minn. — May 7, 2018 — IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its first quarter ende

Submission of Matters to a Vote of Security Holders

8-K 1 intricon1810588k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 26, 2018 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of

IIN / Intricon Corp. ADDITIONAL DEFINITIVE MATERIALS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)

IIN / Intricon Corp. DIFINTIVE PROXY STATEMENT

DEF 14A 1 intricon180651def14a.htm DIFINTIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential,

Form of Restricted Stock Unit Agreement issued to directors pursuant to the 2015 Equity Incentive Plan. (Incorporated by reference from the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.)

Exhibit 10.24 «Date» «FullName» IntriCon Corporation 1260 Red Fox Road Arden Hills, MN 55112 Dear «M1stName»: I am pleased to inform you that on «GrantDate», you were awarded an automatic grant of Restricted Stock Units for «Shares» of Common Stock of the Company (“RSUs”) under the Company’s 2015 Equity Incentive Plan (the “Plan”). The RSUs will vest on the following dates (each a “Vesting Date”):

Amended and Restated Term Note from the Company, Intricon, Inc., I-Management, LLC and Hearing Help Express, Inc. to CIBC Bank USA (formerly known as The PrivateBank and Trust Company), dated December 15, 2017. (Incorporated by reference from the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.)

Exhibit 10.14.5 AMENDED AND RESTATED TERM NOTE $6,500,000 Minneapolis, Minnesota December 15, 2017 FOR VALUE RECEIVED, the undersigned, INTRICON CORPORATION, a Pennsylvania corporation, INTRICON, INC., a Minnesota corporation, I-MANAGEMENT, LLC, a Minnesota limited liability company, and HEARING HELP EXPRESS, INC., an Illinois corporation (each, a “Borrower”; collectively, the “Borrowers”), hereby

Eleventh Amendment to Loan and Security Agreement and Waiver among the Company, Intricon, Inc., I-Management, LLC, Hearing Help Express, Inc., and CIBC Bank USA (formerly known as The PrivateBank and Trust Company), dated as of December 15, 2017. Exhibit A to this Amendment contains the fully amended Loan and Security Agreement among the parties. (Incorporated by reference from the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.)

Exhibit 10.12.12 ELEVENTH AMENDMENT TO Loan AND SECURITY AGREEMENT, WAIVER AND JOINDER THIS ELEVENTH AMENDMENT TO Loan AND SECURITY AGREEMENT, WAIVER AND JOINDER (this “Amendment”) is made and entered into as of December 15, 2017, by and among INTRICON CORPORATION, a Pennsylvania corporation (“IntriCon”), INTRICON, INC., a Minnesota corporation (“Inc.”, and, together with IntriCon, the “Existing B

IIN / Intricon Corp. FORM 10K FOR THE FISCAL YEAR ENDED DECEMBER 31, 2017 (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark one) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 1-5005 INTRICON CORPORA

Significant Subsidiaries of IntriCon Corporation

EXHIBIT 21.1 Significant Subsidiaries of IntriCon Corporation Subsidiary Place of Incorporation IntriCon GmbH Vertrieb von Elecktronikteilen Germany IntriCon UK Limited United Kingdom IntriCon, Inc. Minnesota IntriCon PTE LTD. Singapore PT IntriCon Indonesia Indonesia Hearing Help Express, Inc. Illinois

Form of Restricted Stock Unit Agreement issued to employees pursuant to the 2015 Equity Incentive Plan. (Incorporated by reference from the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.)

Exhibit 10.23 «Date» «FullName» IntriCon Corporation 1260 Red Fox Road Arden Hills, MN 55112 Dear «M1stName»: I am pleased to inform you that on «GrantDate» the Compensation Committee of the Board of Directors of IntriCon Corporation granted you Restricted Stock Units for «Shares» of Common Stock of the Company (“RSUs”) under the Company’s 2015 Equity Incentive Plan (the “Plan”). The RSUs will ves

CAPEX NOTE

Exhibit 10.15.1 CAPEX NOTE $2,500,000 Minneapolis, Minnesota December 15, 2017 FOR VALUE RECEIVED, the undersigned, INTRICON CORPORATION, a Pennsylvania corporation, INTRICON, INC., a Minnesota corporation, I-MANAGEMENT, LLC, a Minnesota limited liability company, and HEARING HELP EXPRESS, INC., an Illinois corporation (each, a “Borrower”; collectively, the “Borrowers”), hereby JOINTLY AND SEVERAL

Form of Performance Stock Option Agreement issued to employees pursuant to the 2015 Equity Incentive Plan. (Incorporated by reference from the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.)

Exhibit 10.22 «Date» «FullName» IntriCon Corporation 1260 Red Fox Road Arden Hills, MN 55112 Dear «M1stName»: I am pleased to inform you that on «GrantDate» the Compensation Committee of the Board of Directors of IntriCon Corporation granted you options to purchase «Shares» Common Shares of the Company under the Company’s 2015 Equity Incentive Plan (the “Plan”) at an exercise price of $«Price» per

IIN / Intricon Corp. FORM 8-K/A (Current Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 12, 2018 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorpo

INTRICON REPORTS 2017 FOURTH-QUARTER AND FULL-YEAR RESULTS Medical and Value Hearing Health Performance Drive Double-Digit Fourth Quarter Sales Gains and Record Year

Exhibit 99.1 INTRICON REPORTS 2017 FOURTH-QUARTER AND FULL-YEAR RESULTS Medical and Value Hearing Health Performance Drive Double-Digit Fourth Quarter Sales Gains and Record Year ARDEN HILLS, Minn. — February 12, 2018 (revised February 13, 2018)* — IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today annou

INTRICON REPORTS 2017 FOURTH-QUARTER AND FULL-YEAR RESULTS Medical and Value Hearing Health Performance Drive Double-Digit Fourth Quarter Sales Gains and Record Year

Exhibit 99.1 INTRICON REPORTS 2017 FOURTH-QUARTER AND FULL-YEAR RESULTS Medical and Value Hearing Health Performance Drive Double-Digit Fourth Quarter Sales Gains and Record Year ARDEN HILLS, Minn. ? February 12, 2018 ? IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for it

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 12, 2018 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission

IIN / Intricon Corp. / HEARTLAND ADVISORS INC - AMENDMENT NO. 2 TO SCHEDULE 13G Passive Investment

SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* IntriCon Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 46121H109 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to

INTRICON COMPLETES ACQUISITION OF HEARING HELP EXPRESS Company Also Amends Credit Facilities, Increasing Domestic Borrowing Capacity and Improving Financial Flexibility

Exhibit 99.1 FOR IMMEDIATE RELEASE INTRICON COMPLETES ACQUISITION OF HEARING HELP EXPRESS Company Also Amends Credit Facilities, Increasing Domestic Borrowing Capacity and Improving Financial Flexibility ARDEN HILLS, Minn. ? December 18, 2017 ? IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, announced that

IIN / Intricon Corp. FORM 8-K DATED DECEMBER 15, 2017 (Current Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 15, 2017 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission

IIN / Intricon Corp. FORM 10-Q DATED 9-30-2017 (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-5005 INTRIC

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 6, 2017 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission F

INTRICON REPORTS 2017 THIRD-QUARTER RESULTS Medical and Value Hearing Health Performance Drive Second Consecutive Quarter of Record Sales

Exhibit 99.1 INTRICON REPORTS 2017 THIRD-QUARTER RESULTS Medical and Value Hearing Health Performance Drive Second Consecutive Quarter of Record Sales ARDEN HILLS, Minn. ? November 6, 2017 ? IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its third quarter ended Septemb

IIN / Intricon Corp. FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2017 (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-5005 INTRICON CO

INTRICON REPORTS 2017 SECOND-QUARTER RESULTS Significant Gains in Medical and Value Hearing Health Drive Record Sales

INTRICON REPORTS 2017 SECOND-QUARTER RESULTS Significant Gains in Medical and Value Hearing Health Drive Record Sales ARDEN HILLS, Minn.

Intricon FORM 8-K DATED AUGUST 2, 2017 (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 2, 2017 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission Fil

INTRICON COMPLETES INTRODUCTION OF ADVANCED DIGITAL HEARING DEVICES INTO HEARING HELP EXPRESS’ PRODUCT LINE Company Comments on Recent Stock Price Activity

Exhibit 99.1 FOR IMMEDIATE RELEASE INTRICON COMPLETES INTRODUCTION OF ADVANCED DIGITAL HEARING DEVICES INTO HEARING HELP EXPRESS? PRODUCT LINE Company Comments on Recent Stock Price Activity ARDEN HILLS, Minn. ? June 22, 2017 ? IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced that it has comp

Intricon FORM 8-K DATED JUNE 22, 2017 (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 22, 2017 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission File

Conflict Minerals Report of IntriCon Corporation in Accordance with Rule 13p-1 under the Securities Exchange Act of 1934

Exhibit 1.01 Conflict Minerals Report of IntriCon Corporation in Accordance with Rule 13p-1 under the Securities Exchange Act of 1934 Explanatory Note This is the Conflict Minerals Report (the ?Report?) of IntriCon Corporation (the ?Company?) for calendar year 2016 in accordance with Rule 13p-1 (?Rule 13p-1?) under the Securities Exchange Act of 1934 (the ?1934 Act?). Please refer to Rule 13p-1, F

Intricon FORM SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report IntriCon Corporation (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction (Commission (IRS Employer of incorporation or organization) File Number) Identification No.) 1260 Red Fox Road, Arden Hills, Minnesota 55112 (Address of p

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-5005 INTRICON C

Investment Agreement dated as of April 19, 2017 among IntriCon, Inc., Rheinton GmbH and Soundperience GmbH (English translation). (Incorporated by reference from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2017.)

English Convenience Translation – Original Agreement has been executed in German language – Dated 19 April 2017 Rheinton GmbH as Shareholder and IntriCon Inc.

Submission of Matters to a Vote of Security Holders

8-K 1 intricon1714008k.htm FORM 8-K DATED APRIL 27, 2017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 27, 2017 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (Stat

Intricon FORM 8-K DATED APRIL 25, 2017 (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 25, 2017 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of (Commission File Number) (IRS

INTRICON REPORTS 2017 FIRST-QUARTER RESULTS Gains in Medical and Value Hearing Health Drive Record Sales; Company to Acquire 49 Percent Stake in Soundperience

Exhibit 99.1 INTRICON REPORTS 2017 FIRST-QUARTER RESULTS Gains in Medical and Value Hearing Health Drive Record Sales; Company to Acquire 49 Percent Stake in Soundperience ARDEN HILLS, Minn. ? April 25, 2017 ? IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its first qu

IIN / Intricon Corp. / HEARTLAND ADVISORS INC - AMENDMENT NO. 1 TO SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* IntriCon Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 46121H109 (CUSIP Number) March 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched

Intricon ADDITIONAL DEFINITIVE PROXY MATERIALS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)

Intricon DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)

AMENDED AND RESTATED OFFICE/WAREHOUSE LEASE FOURTH EXTENSION AGREEMENT (1260 Red Fox Road, Arden Hills, Minnesota)

EXHIBIT 10.2.4 AMENDED AND RESTATED OFFICE/WAREHOUSE LEASE FOURTH EXTENSION AGREEMENT (1260 Red Fox Road, Arden Hills, Minnesota) This Amended and Restated Office/Warehouse Lease Fourth Extension Agreement (?Fourth Amendment?) is made March 10, 2017 (?Effective Date?), by Arden Partners I, L.L.P., a Minnesota limited liability partnership (?Lessor?) and IntriCon, Inc., a Minnesota corporation (?Le

Significant Subsidiaries of IntriCon Corporation

EXHIBIT 21.1 Significant Subsidiaries of IntriCon Corporation Subsidiary Place of Incorporation IntriCon GmbH Vertrieb von Elecktronikteilen Germany IntriCon UK Limited United Kingdom IntriCon, Inc. Minnesota IntriCon PTE LTD. Singapore PT IntriCon Indonesia Indonesia Hearing Help Express, Inc. Illinois

- 2 -

EXHIBIT 10.2.5 GUARANTY GUARANTY made March 10, 2017, by IntriCon Corporation, a Pennsylvania corporation (the ?Guarantor?) in favor of Arden Partners I, L.L.P., a Minnesota limited liability partnership (?Arden?). WHEREAS, Guarantor owns all of the issued and outstanding shares of stock in IntriCon, Inc., a Minnesota corporation (?Company?); and WHEREAS, Arden, as Lessor, and Company, as Lessee,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark one) ? ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 or ? TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 1-5005 INTRICON CORPORA

TENTH AMENDMENT TO Loan AND SECURITY AGREEMENT AND WAIVER

EXHIBIT 10.14.11 TENTH AMENDMENT TO Loan AND SECURITY AGREEMENT AND WAIVER THIS TENTH AMENDMENT TO Loan AND SECURITY AGREEMENT AND WAIVER (this ?Amendment?) is made and entered into as of March 9, 2017, by and among INTRICON CORPORATION, a Pennsylvania corporation, INTRICON, INC., a Minnesota corporation (each, a ?Borrower?; collectively, the ?Borrowers?), and THE PRIVATEBANK AND TRUST COMPANY, an

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 17, 2017 INTRICON CORPORATION (Exact name of registrant as specified in its charter) Pennsylvania 1-5005 23-1069060 (State or other jurisdiction of incorporation) (Commission

INTRICON REPORTS 2016 FOURTH-QUARTER RESULTS Hearing Health Revenues Rise; Company’s Medical Business Grows $1.0 Million Sequentially

Exhibit 99.1 INTRICON REPORTS 2016 FOURTH-QUARTER RESULTS Hearing Health Revenues Rise; Company’s Medical Business Grows $1.0 Million Sequentially ARDEN HILLS, Minn. — February 16, 2017 — IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its fourth quarter ended December